Stocks
Sorrento Therapeutics, Inc.SRNE
OTCHealthcareBiotechnology$0.00+22.58%
A clinical-stage biotechnology company focused on developing antibody-based therapies for cancer, immunology, and pain management. The firm has pursued a broad pipeline including immunotherapies, cell therapies, and antiviral treatments, while facing significant financial pressure and restructuring ...
Market Cap: $2.1M52W Range: $0.00 – $0.10
Congressional Interest in Sorrento Therapeutics, Inc. (SRNE)
1 member of Congress has disclosed 2 trades in Sorrento Therapeutics, Inc. (SRNE), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading SRNE?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-01-04 | Christopher L. Jacobs | sell | $1K – $15K |
| 2020-12-28 | Christopher L. Jacobs | buy | $1K – $15K |